MISFOLDED TDP-43 BINDING MOLECULES
The present invention is in the field of transactive response DNA binding protein with a molecular weight of 43 kDa (TARDB or also TDP-43). The invention relates to TDP-43 specific binding molecules,in particular to anti-TDP-43 antibodies or an antigen-binding fragment or a derivative thereof and us...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
03.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention is in the field of transactive response DNA binding protein with a molecular weight of 43 kDa (TARDB or also TDP-43). The invention relates to TDP-43 specific binding molecules,in particular to anti-TDP-43 antibodies or an antigen-binding fragment or a derivative thereof and uses thereof. The present invention provides means and methods to diagnose, prevent, alleviate and/ortreat a disorder and/or abnormality associated with misfolded TDP-43 including but not limited to frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD, sporadicand familial), and/or Parkinson's disease (PD). The present invention provides modified conformation-specific antigenic peptides and peptide fragments derived from the TDP-43 protein and the antibodies obtainable by said peptides or fragments for use in the diagnosis, prevention, alleviation and/or treatment of TDP-43-related disorders and/or abnormalities.
本发明属于分子量为43kDa的反式激活应答DNA结合蛋白(TARDB或也称为TDP-43)的领域。本发明涉及TDP-43特异性结合分 |
---|---|
Bibliography: | Application Number: CN201980012546 |